 Joanne Masterson
Concepts (277)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eosinophilic Esophagitis | 21 | 2024 | 308 | 6.100 |
Why?
| | Eosinophils | 17 | 2021 | 282 | 3.520 |
Why?
| | Eosinophilia | 9 | 2021 | 184 | 2.980 |
Why?
| | Claudins | 3 | 2024 | 24 | 2.260 |
Why?
| | Enteritis | 4 | 2022 | 78 | 2.040 |
Why?
| | Epithelial Cells | 11 | 2024 | 963 | 2.020 |
Why?
| | Tight Junctions | 4 | 2024 | 69 | 1.620 |
Why?
| | Gastroesophageal Reflux | 5 | 2023 | 248 | 1.550 |
Why?
| | MicroRNAs | 4 | 2024 | 637 | 1.360 |
Why?
| | Esophagus | 10 | 2019 | 237 | 1.350 |
Why?
| | Gastritis | 3 | 2021 | 82 | 1.230 |
Why?
| | Esophagitis | 2 | 2018 | 66 | 1.190 |
Why?
| | Claudin-1 | 2 | 2019 | 17 | 0.840 |
Why?
| | Colitis | 6 | 2017 | 219 | 0.820 |
Why?
| | Esophageal Mucosa | 2 | 2019 | 18 | 0.780 |
Why?
| | Barrett Esophagus | 1 | 2023 | 154 | 0.770 |
Why?
| | Intestines | 2 | 2021 | 332 | 0.740 |
Why?
| | Ileitis | 4 | 2015 | 25 | 0.720 |
Why?
| | Esophageal Neoplasms | 1 | 2023 | 281 | 0.710 |
Why?
| | Eosinophil Peroxidase | 2 | 2018 | 7 | 0.710 |
Why?
| | Gastrointestinal Diseases | 2 | 2019 | 187 | 0.690 |
Why?
| | Ileum | 2 | 2015 | 100 | 0.650 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2019 | 246 | 0.620 |
Why?
| | Receptors, CCR3 | 2 | 2018 | 8 | 0.580 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2017 | 164 | 0.570 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2017 | 143 | 0.570 |
Why?
| | Crohn Disease | 4 | 2015 | 197 | 0.550 |
Why?
| | Anti-Inflammatory Agents | 3 | 2014 | 465 | 0.550 |
Why?
| | Fibrosis | 2 | 2015 | 483 | 0.540 |
Why?
| | Interleukin-33 | 1 | 2015 | 39 | 0.530 |
Why?
| | Vascular Remodeling | 1 | 2017 | 152 | 0.520 |
Why?
| | Inflammation | 7 | 2024 | 2566 | 0.520 |
Why?
| | Intestinal Mucosa | 7 | 2016 | 531 | 0.510 |
Why?
| | Epithelium | 5 | 2019 | 305 | 0.500 |
Why?
| | Disease Models, Animal | 8 | 2017 | 3730 | 0.460 |
Why?
| | Mice, Transgenic | 4 | 2019 | 2025 | 0.460 |
Why?
| | Signal Transduction | 7 | 2019 | 4709 | 0.460 |
Why?
| | Interleukin-5 | 1 | 2012 | 31 | 0.450 |
Why?
| | Acute Lung Injury | 2 | 2017 | 310 | 0.420 |
Why?
| | Celiac Disease | 1 | 2015 | 267 | 0.410 |
Why?
| | Bone Morphogenetic Protein 4 | 2 | 2010 | 34 | 0.410 |
Why?
| | Leukocyte Count | 3 | 2021 | 305 | 0.390 |
Why?
| | Cadherins | 3 | 2010 | 186 | 0.370 |
Why?
| | Asthma | 2 | 2021 | 2158 | 0.360 |
Why?
| | Humans | 41 | 2024 | 118972 | 0.360 |
Why?
| | Mice | 17 | 2023 | 15520 | 0.350 |
Why?
| | Regeneration | 1 | 2010 | 165 | 0.340 |
Why?
| | Cell Line, Transformed | 2 | 2019 | 136 | 0.320 |
Why?
| | Lung | 4 | 2018 | 3664 | 0.320 |
Why?
| | Animals | 22 | 2023 | 33381 | 0.320 |
Why?
| | Bromodeoxyuridine | 1 | 2007 | 76 | 0.310 |
Why?
| | Child | 18 | 2021 | 19129 | 0.310 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2007 | 58 | 0.310 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2007 | 83 | 0.300 |
Why?
| | DNA, Neoplasm | 1 | 2007 | 154 | 0.300 |
Why?
| | Proton Pump Inhibitors | 3 | 2018 | 98 | 0.300 |
Why?
| | DNA Damage | 1 | 2007 | 357 | 0.260 |
Why?
| | Cell Cycle | 1 | 2007 | 550 | 0.250 |
Why?
| | Child, Preschool | 9 | 2019 | 9491 | 0.250 |
Why?
| | Protein Processing, Post-Translational | 1 | 2007 | 408 | 0.250 |
Why?
| | Receptors, CCR7 | 2 | 2015 | 24 | 0.240 |
Why?
| | Hypercapnia | 1 | 2023 | 50 | 0.230 |
Why?
| | Mucosal-Associated Invariant T Cells | 1 | 2022 | 14 | 0.220 |
Why?
| | Hidradenitis Suppurativa | 1 | 2022 | 9 | 0.220 |
Why?
| | Male | 18 | 2021 | 57801 | 0.220 |
Why?
| | Adolescent | 13 | 2019 | 18480 | 0.220 |
Why?
| | Th1 Cells | 2 | 2015 | 133 | 0.210 |
Why?
| | Bone Morphogenetic Proteins | 2 | 2016 | 137 | 0.210 |
Why?
| | Dexamethasone | 3 | 2012 | 320 | 0.200 |
Why?
| | Female | 19 | 2021 | 61564 | 0.200 |
Why?
| | Immunoglobulin G | 2 | 2018 | 788 | 0.200 |
Why?
| | Disease Progression | 3 | 2023 | 2490 | 0.200 |
Why?
| | Biopsy | 4 | 2019 | 1079 | 0.190 |
Why?
| | Mice, Inbred C57BL | 6 | 2017 | 4908 | 0.190 |
Why?
| | GATA3 Transcription Factor | 2 | 2018 | 26 | 0.180 |
Why?
| | Nanoparticles | 3 | 2018 | 325 | 0.180 |
Why?
| | Homeostasis | 2 | 2021 | 594 | 0.180 |
Why?
| | Antibodies, Monoclonal | 3 | 2017 | 1284 | 0.180 |
Why?
| | Patient Reported Outcome Measures | 1 | 2021 | 252 | 0.170 |
Why?
| | Hypersensitivity | 3 | 2018 | 268 | 0.170 |
Why?
| | Cytokines | 4 | 2016 | 1900 | 0.170 |
Why?
| | Protein Stability | 1 | 2019 | 164 | 0.170 |
Why?
| | Microbiota | 2 | 2016 | 656 | 0.160 |
Why?
| | Colonic Diseases | 1 | 2018 | 26 | 0.160 |
Why?
| | Phenotype | 3 | 2022 | 3003 | 0.160 |
Why?
| | Case-Control Studies | 2 | 2023 | 3171 | 0.160 |
Why?
| | Respiratory Hypersensitivity | 1 | 2018 | 65 | 0.160 |
Why?
| | Cell Movement | 5 | 2018 | 896 | 0.160 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2012 | 982 | 0.160 |
Why?
| | Hypoxia | 1 | 2024 | 963 | 0.150 |
Why?
| | Chemotactic Factors, Eosinophil | 1 | 2017 | 6 | 0.150 |
Why?
| | Chemokine CCL24 | 2 | 2019 | 9 | 0.150 |
Why?
| | Electric Impedance | 1 | 2017 | 101 | 0.150 |
Why?
| | Mucous Membrane | 3 | 2013 | 113 | 0.150 |
Why?
| | Real-Time Polymerase Chain Reaction | 3 | 2012 | 333 | 0.150 |
Why?
| | Gastrointestinal Tract | 1 | 2019 | 175 | 0.150 |
Why?
| | Gene Expression Regulation | 3 | 2019 | 2445 | 0.150 |
Why?
| | Antibodies | 2 | 2017 | 392 | 0.150 |
Why?
| | Smad Proteins | 1 | 2016 | 39 | 0.140 |
Why?
| | Colon | 1 | 2018 | 238 | 0.140 |
Why?
| | Gene Expression | 2 | 2023 | 1489 | 0.140 |
Why?
| | Myeloid Cells | 1 | 2017 | 128 | 0.140 |
Why?
| | Probiotics | 1 | 2016 | 49 | 0.140 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2017 | 150 | 0.140 |
Why?
| | G(M1) Ganglioside | 1 | 2015 | 7 | 0.140 |
Why?
| | Inflammasomes | 1 | 2017 | 120 | 0.140 |
Why?
| | RNA, Ribosomal, 16S | 2 | 2015 | 514 | 0.130 |
Why?
| | Peroxidase | 1 | 2015 | 170 | 0.130 |
Why?
| | Receptor, Adenosine A2B | 1 | 2015 | 32 | 0.130 |
Why?
| | RNA, Small Interfering | 1 | 2017 | 564 | 0.130 |
Why?
| | Cell Culture Techniques | 1 | 2017 | 356 | 0.130 |
Why?
| | Fibronectins | 1 | 2015 | 114 | 0.130 |
Why?
| | Interleukin-13 | 1 | 2015 | 135 | 0.130 |
Why?
| | Desmosomes | 1 | 2014 | 19 | 0.130 |
Why?
| | Neutrophils | 2 | 2017 | 1233 | 0.130 |
Why?
| | Constriction, Pathologic | 1 | 2015 | 203 | 0.130 |
Why?
| | Hypoxia-Inducible Factor 1 | 1 | 2015 | 64 | 0.130 |
Why?
| | Down-Regulation | 1 | 2017 | 627 | 0.130 |
Why?
| | Mice, Inbred C3H | 2 | 2016 | 250 | 0.130 |
Why?
| | Th17 Cells | 1 | 2015 | 57 | 0.130 |
Why?
| | Bronchi | 1 | 2016 | 242 | 0.130 |
Why?
| | Cell Adhesion Molecules | 1 | 2015 | 180 | 0.120 |
Why?
| | Permeability | 2 | 2011 | 156 | 0.120 |
Why?
| | Chemokines | 1 | 2015 | 230 | 0.120 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 1137 | 0.120 |
Why?
| | Th2 Cells | 2 | 2018 | 164 | 0.120 |
Why?
| | Trachea | 1 | 2016 | 226 | 0.120 |
Why?
| | RNA, Bacterial | 1 | 2015 | 175 | 0.120 |
Why?
| | Inflammatory Bowel Diseases | 3 | 2017 | 290 | 0.120 |
Why?
| | Adult | 8 | 2021 | 31512 | 0.120 |
Why?
| | beta-Defensins | 1 | 2013 | 22 | 0.110 |
Why?
| | Collagen | 1 | 2015 | 433 | 0.110 |
Why?
| | Oxazolone | 1 | 2012 | 5 | 0.110 |
Why?
| | Viral Regulatory and Accessory Proteins | 1 | 2012 | 28 | 0.110 |
Why?
| | Biomarkers | 5 | 2019 | 3588 | 0.110 |
Why?
| | Neoplasms | 1 | 2007 | 2179 | 0.110 |
Why?
| | Killer Cells, Natural | 1 | 2015 | 381 | 0.110 |
Why?
| | Peptides | 1 | 2018 | 879 | 0.110 |
Why?
| | Mucositis | 1 | 2012 | 20 | 0.110 |
Why?
| | Inflammation Mediators | 1 | 2015 | 502 | 0.110 |
Why?
| | Ischemia | 1 | 2015 | 374 | 0.110 |
Why?
| | Chemokine CCL19 | 1 | 2012 | 6 | 0.110 |
Why?
| | Chemokine CCL21 | 1 | 2012 | 13 | 0.110 |
Why?
| | Autophagy | 1 | 2016 | 315 | 0.110 |
Why?
| | Pregnenediones | 1 | 2012 | 21 | 0.110 |
Why?
| | Herpesvirus 4, Human | 1 | 2012 | 126 | 0.110 |
Why?
| | Choristoma | 1 | 2012 | 24 | 0.100 |
Why?
| | Chemokine CCL11 | 1 | 2011 | 22 | 0.100 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2015 | 359 | 0.100 |
Why?
| | Anti-Allergic Agents | 1 | 2012 | 41 | 0.100 |
Why?
| | Fibroblasts | 1 | 2016 | 842 | 0.100 |
Why?
| | Cells, Cultured | 2 | 2017 | 4077 | 0.100 |
Why?
| | Neutrophil Infiltration | 1 | 2011 | 97 | 0.100 |
Why?
| | Nerve Growth Factors | 1 | 2011 | 74 | 0.100 |
Why?
| | Kidney Diseases | 1 | 2015 | 439 | 0.100 |
Why?
| | Smad Proteins, Receptor-Regulated | 1 | 2010 | 2 | 0.100 |
Why?
| | Mice, Inbred Strains | 1 | 2011 | 405 | 0.100 |
Why?
| | Naphthalenes | 1 | 2010 | 41 | 0.090 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2012 | 176 | 0.090 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2010 | 154 | 0.090 |
Why?
| | T-Lymphocyte Subsets | 1 | 2012 | 396 | 0.090 |
Why?
| | Infant | 3 | 2018 | 8293 | 0.090 |
Why?
| | Up-Regulation | 1 | 2012 | 872 | 0.090 |
Why?
| | Tumor Suppressor Proteins | 1 | 2011 | 289 | 0.090 |
Why?
| | Flow Cytometry | 4 | 2015 | 1085 | 0.080 |
Why?
| | Kidney | 1 | 2015 | 1353 | 0.080 |
Why?
| | beta-Galactosidase | 1 | 2007 | 65 | 0.080 |
Why?
| | Monocytes | 2 | 2023 | 513 | 0.080 |
Why?
| | Retrospective Studies | 4 | 2018 | 12978 | 0.070 |
Why?
| | Mesoderm | 1 | 2008 | 141 | 0.070 |
Why?
| | Interleukin-1 | 1 | 2011 | 980 | 0.070 |
Why?
| | Diagnosis, Differential | 3 | 2018 | 1384 | 0.070 |
Why?
| | Matrix Metalloproteinases | 1 | 2007 | 90 | 0.070 |
Why?
| | Chronic Disease | 1 | 2011 | 1636 | 0.070 |
Why?
| | Mice, Knockout | 3 | 2017 | 2680 | 0.070 |
Why?
| | Rats, Sprague-Dawley | 1 | 2010 | 2478 | 0.060 |
Why?
| | Dextran Sulfate | 2 | 2017 | 71 | 0.060 |
Why?
| | Cell Cycle Proteins | 1 | 2007 | 565 | 0.060 |
Why?
| | Genes, Mitochondrial | 1 | 2023 | 14 | 0.060 |
Why?
| | Cell Proliferation | 2 | 2008 | 2275 | 0.060 |
Why?
| | Cell Line | 3 | 2018 | 2707 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2436 | 0.060 |
Why?
| | Esophagoscopy | 2 | 2016 | 190 | 0.060 |
Why?
| | Fluorescent Antibody Technique | 2 | 2015 | 410 | 0.050 |
Why?
| | Interleukin-1beta | 2 | 2017 | 379 | 0.050 |
Why?
| | Rats | 1 | 2010 | 5392 | 0.050 |
Why?
| | Carbon Dioxide | 1 | 2023 | 230 | 0.050 |
Why?
| | Mice, Mutant Strains | 2 | 2012 | 280 | 0.050 |
Why?
| | International Cooperation | 1 | 2021 | 177 | 0.050 |
Why?
| | Acute Disease | 2 | 2015 | 940 | 0.050 |
Why?
| | Cell Line, Tumor | 1 | 2007 | 2851 | 0.050 |
Why?
| | Fatty Acids | 1 | 2023 | 407 | 0.050 |
Why?
| | Cell Differentiation | 1 | 2007 | 1753 | 0.050 |
Why?
| | Chemokine CCL26 | 1 | 2019 | 7 | 0.050 |
Why?
| | Lipopolysaccharides | 1 | 2023 | 870 | 0.040 |
Why?
| | Endoscopy, Digestive System | 1 | 2019 | 111 | 0.040 |
Why?
| | Middle Aged | 4 | 2021 | 27617 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2015 | 1171 | 0.040 |
Why?
| | Sensitivity and Specificity | 2 | 2013 | 1795 | 0.040 |
Why?
| | RNA Transport | 1 | 2017 | 22 | 0.040 |
Why?
| | GTP-Binding Proteins | 1 | 2018 | 147 | 0.040 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2017 | 87 | 0.040 |
Why?
| | Receptors, CCR2 | 1 | 2017 | 30 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2018 | 2657 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2019 | 749 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2017 | 311 | 0.040 |
Why?
| | Hematopoiesis | 1 | 2017 | 175 | 0.030 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2016 | 57 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2018 | 508 | 0.030 |
Why?
| | Cell Communication | 1 | 2017 | 281 | 0.030 |
Why?
| | Chloroquine | 1 | 2016 | 64 | 0.030 |
Why?
| | Macaca mulatta | 1 | 2016 | 153 | 0.030 |
Why?
| | Immunity, Mucosal | 1 | 2016 | 86 | 0.030 |
Why?
| | Young Adult | 3 | 2019 | 10793 | 0.030 |
Why?
| | Respiratory System | 1 | 2016 | 141 | 0.030 |
Why?
| | In Situ Nick-End Labeling | 1 | 2015 | 124 | 0.030 |
Why?
| | Disease Susceptibility | 1 | 2017 | 331 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2015 | 136 | 0.030 |
Why?
| | Lung Neoplasms | 1 | 2007 | 2220 | 0.030 |
Why?
| | Allergens | 1 | 2018 | 424 | 0.030 |
Why?
| | Keratinocytes | 1 | 2016 | 227 | 0.030 |
Why?
| | Adoptive Transfer | 1 | 2015 | 204 | 0.030 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2014 | 140 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2015 | 363 | 0.030 |
Why?
| | Models, Animal | 1 | 2016 | 363 | 0.030 |
Why?
| | Isoenzymes | 1 | 2015 | 297 | 0.030 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2015 | 134 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2015 | 574 | 0.030 |
Why?
| | Transcriptional Activation | 1 | 2015 | 348 | 0.030 |
Why?
| | Base Sequence | 1 | 2017 | 2159 | 0.030 |
Why?
| | Expressed Sequence Tags | 1 | 2012 | 38 | 0.030 |
Why?
| | Eosinophil Granule Proteins | 1 | 2012 | 21 | 0.030 |
Why?
| | Lysophospholipase | 1 | 2012 | 13 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2015 | 1206 | 0.030 |
Why?
| | Protein Binding | 1 | 2018 | 1975 | 0.030 |
Why?
| | Carboxylic Ester Hydrolases | 1 | 2012 | 18 | 0.030 |
Why?
| | Antigens, CD | 1 | 2015 | 460 | 0.030 |
Why?
| | Blotting, Western | 1 | 2015 | 1194 | 0.030 |
Why?
| | Genes, Bacterial | 1 | 2012 | 162 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2015 | 453 | 0.030 |
Why?
| | Diet Therapy | 1 | 2012 | 38 | 0.030 |
Why?
| | Vimentin | 1 | 2012 | 62 | 0.030 |
Why?
| | Pneumonia | 1 | 2017 | 592 | 0.030 |
Why?
| | Netrin-1 | 1 | 2011 | 11 | 0.030 |
Why?
| | Genome, Bacterial | 1 | 2012 | 109 | 0.030 |
Why?
| | Lymphoid Tissue | 1 | 2012 | 65 | 0.030 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2012 | 133 | 0.030 |
Why?
| | Keratins | 1 | 2012 | 174 | 0.030 |
Why?
| | Metagenome | 1 | 2012 | 121 | 0.030 |
Why?
| | Dendritic Cells | 1 | 2015 | 442 | 0.030 |
Why?
| | Remission Induction | 1 | 2012 | 247 | 0.030 |
Why?
| | Transendothelial and Transepithelial Migration | 1 | 2011 | 27 | 0.030 |
Why?
| | Gastric Mucosa | 1 | 2011 | 45 | 0.030 |
Why?
| | Specimen Handling | 1 | 2012 | 165 | 0.020 |
Why?
| | Equipment Design | 1 | 2012 | 519 | 0.020 |
Why?
| | Glycoproteins | 1 | 2012 | 319 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2015 | 1158 | 0.020 |
Why?
| | Quality of Life | 1 | 2021 | 2366 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2012 | 649 | 0.020 |
Why?
| | Endoscopy | 1 | 2012 | 272 | 0.020 |
Why?
| | Gastrointestinal Microbiome | 1 | 2016 | 548 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 827 | 0.020 |
Why?
| | Models, Genetic | 1 | 2012 | 595 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2012 | 755 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2016 | 1178 | 0.020 |
Why?
| | Transforming Growth Factor beta | 1 | 2012 | 462 | 0.020 |
Why?
| | Adrenal Cortex Hormones | 1 | 2012 | 521 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2011 | 1293 | 0.020 |
Why?
| | Immunologic Memory | 1 | 2010 | 313 | 0.020 |
Why?
| | Prospective Studies | 1 | 2019 | 6471 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2012 | 1691 | 0.020 |
Why?
| | Cytoskeleton | 1 | 2008 | 181 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2008 | 412 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2013 | 2874 | 0.020 |
Why?
| | Cell Survival | 1 | 2008 | 1047 | 0.020 |
Why?
| | Aged | 1 | 2021 | 19657 | 0.010 |
Why?
| | Models, Biological | 1 | 2008 | 1715 | 0.010 |
Why?
|
|
Masterson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|